Non-Pharmacological Interventions Show Domain-Specific Cognitive Benefits in Children with Autism Spectrum Disorder
Overview of Recent Research
A systematic review and network meta-analysis published in the Asian Journal of Psychiatry has examined the effectiveness of various non-pharmacological interventions on cognitive functions in children diagnosed with autism spectrum disorder (ASD). The study assessed randomized controlled trials (RCTs) conducted between January 2005 and April 2026, focusing on key cognitive domains such as attention, working memory, comprehensive executive function, and social-emotional cognition.
Key Findings on Cognitive Improvements
Analyzing data from 35 reports involving 1,694 children, researchers found that non-pharmacological interventions were associated with a moderate overall improvement in cognitive outcomes (standardized mean difference [SMD] = 0.54; 95% confidence interval [CI], 0.36 to 0.71). Specifically, working memory showed a significant benefit (SMD = 0.61; 95% CI, 0.09 to 1.13), as did social-emotional cognition (SMD = 0.47; 95% CI, 0.30 to 0.65).
Social-Emotional Cognition and Intervention Types
Among the cognitive domains studied, social-emotional cognition was the only area with a sufficiently connected network of data allowing for comparison across different intervention categories. Within this domain, social-behavioral interventions and technology- or robot-assisted interventions demonstrated the most notable benefits when compared to active control groups.
Limitations and Data Gaps
The evidence networks for attention, working memory, and comprehensive executive function were limited by sparse or disconnected data, restricting the ability to compare intervention types in these areas. Additionally, the confidence in network estimates varied: it was moderate for some social-emotional cognition comparisons but generally low or very low for most other outcomes.
Implications for Families and Practitioners
This analysis suggests that while non-pharmacological interventions may improve certain cognitive functions in children with ASD, the benefits appear to be specific to particular cognitive domains, especially social-emotional cognition. Families and healthcare providers might consider these findings when evaluating intervention options, recognizing that more robust evidence is needed to guide choices for attention and executive function improvements.
Need for Further Research
The authors highlight the necessity for more adequately powered head-to-head RCTs using standardized outcome measures to better understand the comparative effectiveness of different non-pharmacological interventions across all cognitive domains in children with ASD.
For more detailed information, see the original publication: Comparative effects of non-pharmacological intervention categories on cognitive domains in children with autism spectrum disorder.
Download the images in this article
